Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Y M Abs Therapeutics Appoints Norman La France, M.D. As Chief Development Officer

RECENTLY ACQUIREDJun 05, 2024•about 2 years ago

Position

Senior Vice President

Company

Y-MAbs

Norman LaFrance

New YorkBiotechnology

Description

Y-mAbs Therapeutics, Inc announced the appointment of Norman LaFrance, MD as Chief Development Officer. Dr LaFrance brings over 40 years of deep radiopharmaceutical experience as both a nuclear medicine physician and pharmaceutical executive.

Company Information

Company

Y-MAbs

Location

New York, New York, United States

About

Y-MAbs is focused on developing innovative oncology treatments targeting cancer and associated disorders. The company works on advanced therapeutics and has several products in different stages of development. They are committed to improving the lives of patients through precision medicine.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Y-MAbs's next move

Learn about Strategic plan

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months